Table 1.
Demographics and Clinical Characteristics
| Healthy Comparison | Schizophrenia | Analysis | ||||
|---|---|---|---|---|---|---|
| Subjects (N = 17) | Patients (N = 18) | |||||
| Characteristic | Mean | SD | Mean | SD | t | p |
| Age (years) | 23.24 | 4.59 | 28.11 | 7.67 | 2.265 | 0.03 |
| N | N | χ2 | p | |||
| Gender | 0.229 | 0.632 | ||||
| Male | 11 | 13 | ||||
| Female | 6 | 5 | ||||
| Ethnicity | 8.89 | 0.114 | ||||
| African-American | 1 | 4 | ||||
| Asian-American | 0 | 1 | ||||
| Caucasian | 4 | 8 | ||||
| Hispanic | 5 | 4 | ||||
| Mixed | 5 | 1 | ||||
| Declined to report | 2 | 0 | ||||
| Medication | ||||||
| Traditional Antipsychotics | 1 | |||||
| Atypical Antipsychotics | 17 | |||||
| BPRS Total Score (24 item) | 38.22 | 8.00 | ||||
Mean age of members of each cohort revealed a significant difference in the average age of patients vs. controls. The addition of age as a covariate to each of the reported analyses did not affect the final results. No significant differences were found in the frequency of gender or ethnicity between groups.